Los Angeles Capital Management & Equity Research Inc. reduced its position in shares of Harte-Hanks Inc. (NYSE:HHS) by 20.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 81,650 shares of the company’s stock after selling 20,628 shares during the period. Los Angeles Capital Management & Equity Research Inc. owned approximately 0.13% of Harte-Hanks worth $130,000 at the end of the most recent quarter.
Other institutional investors also recently made changes to their positions in the company. JPMorgan Chase & Co. raised its position in shares of Harte-Hanks by 98,406.7% in the first quarter. JPMorgan Chase & Co. now owns 470,862 shares of the company’s stock worth $1,192,000 after buying an additional 470,384 shares in the last quarter. Renaissance Technologies LLC raised its position in shares of Harte-Hanks by 41.1% in the first quarter. Renaissance Technologies LLC now owns 643,200 shares of the company’s stock worth $1,627,000 after buying an additional 187,500 shares in the last quarter. Royce & Associates LP raised its position in shares of Harte-Hanks by 28.2% in the second quarter. Royce & Associates LP now owns 803,400 shares of the company’s stock worth $1,277,000 after buying an additional 176,830 shares in the last quarter. Boston Partners bought a new position in shares of Harte-Hanks during the second quarter worth about $250,000. Finally, Algert Global LLC bought a new position in shares of Harte-Hanks during the first quarter worth about $394,000. Hedge funds and other institutional investors own 44.58% of the company’s stock.
Shares of Harte-Hanks Inc. (NYSE:HHS) traded up 0.62% during midday trading on Monday, reaching $1.63. 26,864 shares of the company’s stock were exchanged. Harte-Hanks Inc. has a 1-year low of $0.85 and a 1-year high of $4.35. The firm has a 50-day moving average of $1.61 and a 200-day moving average of $1.79. The company’s market capitalization is $100.26 million.
Harte-Hanks (NYSE:HHS) last issued its earnings results on Tuesday, August 9th. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.07) by $0.04. The firm earned $97.30 million during the quarter, compared to the consensus estimate of $116.25 million. Harte-Hanks had a positive return on equity of 1.11% and a negative net margin of 38.76%. The firm’s revenue for the quarter was down 10.9% compared to the same quarter last year. During the same period last year, the business earned $0.04 earnings per share. Equities analysts expect that Harte-Hanks Inc. will post ($0.02) earnings per share for the current fiscal year.
HHS has been the subject of a number of recent analyst reports. Zacks Investment Research lowered shares of Harte-Hanks from a “hold” rating to a “strong sell” rating in a research report on Monday, July 25th. BMO Capital Markets reiterated a “hold” rating on shares of Harte-Hanks in a research report on Monday, July 18th. Finally, Singular Research decreased their target price on shares of Harte-Hanks from $4.50 to $3.80 and set a “buy” rating for the company in a research report on Tuesday, June 21st. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company’s stock. Harte-Hanks presently has an average rating of “Hold” and a consensus price target of $3.70.
Harte Hanks, Inc is a multi-channel marketing company. The Company operates through two segments, which include Customer Interaction and Trillium Software. The Customer Interaction segment provides a range of integrated, multi-channel, data-driven solutions for a range of brands around the globe. The Trillium Software segment is engaged in providing enterprise data quality solutions.
Want to see what other hedge funds are holding HHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Harte-Hanks Inc. (NYSE:HHS).
Receive News & Ratings for Harte-Hanks Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Harte-Hanks Inc. and related companies with MarketBeat.com's FREE daily email newsletter.